{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T05:14:23Z","timestamp":1772687663722,"version":"3.50.1"},"reference-count":87,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,9,23]],"date-time":"2021-09-23T00:00:00Z","timestamp":1632355200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,9,23]],"date-time":"2021-09-23T00:00:00Z","timestamp":1632355200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"the Natural Science Key Project of Bengbu Medical College","award":["BYKY2019012ZD"],"award-info":[{"award-number":["BYKY2019012ZD"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81902156"],"award-info":[{"award-number":["81902156"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the National Natural Science Foundation of China Youth Science Foundation Project","award":["81802571"],"award-info":[{"award-number":["81802571"]}]},{"name":"Zhejiang Medical and Health Science and Technology Project","award":["2019RC039"],"award-info":[{"award-number":["2019RC039"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Metabolic pattern reconstruction is an important factor in tumor progression. Metabolism of tumor cells is characterized by abnormal increase in anaerobic glycolysis, regardless of high oxygen concentration, resulting in a significant accumulation of energy from glucose sources. These changes promotes rapid cell proliferation and tumor growth, which is further referenced a process known as the Warburg effect. The current study reconstructed the metabolic pattern in progression of cancer to identify genetic changes specific in cancer cells. A total of 12 common types of solid tumors were included in the current study. Gene set enrichment analysis (GSEA) was performed to analyze 9 glycolysis-related gene sets, which are implicated in the glycolysis process. Univariate and multivariate analyses were used to identify independent prognostic variables for construction of a nomogram based on clinicopathological characteristics and a glycolysis-related gene prognostic index (GRGPI). The prognostic model based on glycolysis genes showed high area under the curve (AUC) in LIHC (Liver hepatocellular carcinoma). The findings of the current study showed that 8 genes (AURKA, CDK1, CENPA, DEPDC1, HMMR, KIF20A, PFKFB4, STMN1) were correlated with overall survival (OS) and recurrence-free survival (RFS). Further analysis showed that the prediction model accurately distinguished between high- and low-risk cancer patients among patients in different clusters in LIHC. A nomogram with a well-fitted calibration curve based on gene expression profiles and clinical characteristics showed good discrimination based on internal and external cohorts. These findings indicate that changes in expression level of metabolic genes implicated in glycolysis can contribute to reconstruction of tumor-related microenvironment.<\/jats:p>","DOI":"10.1038\/s41598-021-98381-2","type":"journal-article","created":{"date-parts":[[2021,9,23]],"date-time":"2021-09-23T10:57:49Z","timestamp":1632394669000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Glycolysis-related gene expression profiling serves as a novel prognosis risk predictor for human hepatocellular carcinoma"],"prefix":"10.1038","volume":"11","author":[{"given":"Lingyu","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yibei","family":"Dai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danhua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuchu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiwei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhihua","family":"Tao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,9,23]]},"reference":[{"key":"98381_CR1","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1038\/s41571-019-0203-7","volume":"16","author":"X Li","year":"2019","unstructured":"Li, X. et al. Navigating metabolic pathways to enhance antitumour immunity and immunotherapy. Nat. Rev. Clin. Oncol. 16, 425\u2013441 (2019).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"98381_CR2","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.cmet.2018.06.006","volume":"28","author":"M Luo","year":"2018","unstructured":"Luo, M. et al. Targeting breast cancer stem cell state equilibrium through modulation of redox signaling. Cell Metab. 28, 69\u201386 (2018).","journal-title":"Cell Metab."},{"key":"98381_CR3","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1016\/j.molcel.2019.08.028","volume":"76","author":"P Chen","year":"2019","unstructured":"Chen, P. et al. Metabolic diversity in human non-small cell lung cancer cells. Mol. Cell 76, 838\u2013851 (2019).","journal-title":"Mol. Cell"},{"key":"98381_CR4","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1038\/ncb3124","volume":"17","author":"LK Boroughs","year":"2015","unstructured":"Boroughs, L. K. & DeBerardinis, R. J. Metabolic pathways promoting cancer cell survival and growth. Nat. Cell Biol. 17, 351\u2013359 (2015).","journal-title":"Nat. Cell Biol."},{"key":"98381_CR5","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.ccell.2017.06.004","volume":"32","author":"SK Shukla","year":"2017","unstructured":"Shukla, S. K. et al. MUC1 and HIF-1alpha signaling crosstalk induces anabolic glucose metabolism to impart gemcitabine resistance to pancreatic cancer. Cancer Cell 32, 71\u201387 (2017).","journal-title":"Cancer Cell"},{"issue":"144","key":"98381_CR6","first-page":"646","volume":"2011","author":"H Douglas","year":"2011","unstructured":"Douglas, H. & Robert, A. W. Hallmarks of cancer: The next generation. Cell 2011(144), 646\u2013674 (2011).","journal-title":"Cell"},{"key":"98381_CR7","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/j.ccell.2018.01.010","volume":"33","author":"L Li","year":"2018","unstructured":"Li, L. et al. Transcriptional regulation of the Warburg effect in cancer by SIX1. Cancer Cell 33, 368\u2013385 (2018).","journal-title":"Cancer Cell"},{"key":"98381_CR8","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.bbcan.2018.06.005","volume":"1870","author":"L Sun","year":"2018","unstructured":"Sun, L., Suo, C., Li, S., Zhang, H. & Gao, P. Metabolic reprogramming for cancer cells and their microenvironment. Beyond the Warburg effect. Biochim. Biophys. Acta Rev. Cancer 1870, 51\u201366 (2018).","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"98381_CR9","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.1158\/0008-5472.CAN-18-2993","volume":"79","author":"JS Ebron","year":"2019","unstructured":"Ebron, J. S. et al. MiR-644a disrupts oncogenic transformation and Warburg effect by direct modulation of multiple genes of tumor-promoting pathways. Cancer Res. 79, 1844\u20131856 (2019).","journal-title":"Cancer Res."},{"key":"98381_CR10","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s10555-019-09796-3","volume":"38","author":"K Ji","year":"2019","unstructured":"Ji, K., Mayernik, L., Moin, K. & Sloane, B. F. Acidosis and proteolysis in the tumor microenvironment. Cancer Metastasis Rev. 38, 103\u2013112 (2019).","journal-title":"Cancer Metastasis Rev."},{"key":"98381_CR11","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.cmet.2014.12.005","volume":"21","author":"EM Palsson-McDermott","year":"2015","unstructured":"Palsson-McDermott, E. M. et al. Pyruvate kinase M2 regulates Hif-1a activity and IL-1b induction and is a critical determinant of the Warburg effect in LPS-activated macrophages. Cell Metab. 21, 65\u201380 (2015).","journal-title":"Cell Metab."},{"key":"98381_CR12","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.cels.2018.06.003","volume":"7","author":"LB Tanner","year":"2018","unstructured":"Tanner, L. B. et al. Four key steps control glycolytic flux in mammalian cells. Cell Syst. 7, 49\u201362 (2018).","journal-title":"Cell Syst."},{"key":"98381_CR13","doi-asserted-by":"publisher","first-page":"3162","DOI":"10.1038\/s41467-020-16966-3","volume":"11","author":"CQ Wang","year":"2020","unstructured":"Wang, C. Q. et al. Interactome analysis reveals that lncRNA HULC promotes aerobic glycolysis through LDHA and PKM2. Nat. Commun. 11, 3162\u20133176 (2020).","journal-title":"Nat. Commun."},{"key":"98381_CR14","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s12964-019-0502-8","volume":"18","author":"WX Dai","year":"2020","unstructured":"Dai, W. X. et al. FOXE1 represses cell proliferation and Warburg effect by inhibiting HK2 in colorectal cancer. Cell Commun. Signal. 18, 7\u201319 (2020).","journal-title":"Cell Commun. Signal."},{"key":"98381_CR15","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1158\/0008-5472.CAN-17-2215","volume":"78","author":"T Houles","year":"2018","unstructured":"Houles, T. et al. RSK regulates PFK-2 activity to promote metabolic rewiring in melanoma. Cancer Res. 78, 2191\u20132204 (2018).","journal-title":"Cancer Res."},{"key":"98381_CR16","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1002\/ijc.32756","volume":"147","author":"YY Zhou","year":"2020","unstructured":"Zhou, Y. Y. et al. Benserazide is a novel inhibitor targeting PKM2 for melanoma treatment. Int. J. Cancer 147, 139\u2013151 (2020).","journal-title":"Int. J. Cancer"},{"key":"98381_CR17","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1186\/s13046-019-1194-z","volume":"38","author":"J Feng","year":"2019","unstructured":"Feng, J. et al. PKM2 is the target of proanthocyanidin B2 during the inhibition of hepatocellular carcinoma. J. Exp. Clin. Cancer Res. 38, 204\u2013228 (2019).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"98381_CR18","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1016\/j.cels.2017.10.014","volume":"5","author":"K Yu","year":"2017","unstructured":"Yu, K. et al. Association of omics features with histopathology patterns in lung adenocarcinoma. Cell Syst. 5, 620\u2013627 (2017).","journal-title":"Cell Syst."},{"key":"98381_CR19","first-page":"465","volume":"8","author":"A Constantine","year":"2019","unstructured":"Constantine, A., Ursula, M., Alex, F., Thomas, P. & Mark, L. Molecular and histopathology directed therapy for advanced bladder cancer. Nat. Rev. Urol. 8, 465\u2013483 (2019).","journal-title":"Nat. Rev. Urol."},{"key":"98381_CR20","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/1471-2164-12-66","volume":"12","author":"MA Thomas","year":"2011","unstructured":"Thomas, M. A., Yang, L., Carter, B. J. & Klaper, R. D. Gene set enrichment analysis of microarray data from Pimephales promelas (Rafinesque), a non-mammalian model organism. BMC Genomics 12, 66\u201374 (2011).","journal-title":"BMC Genomics"},{"key":"98381_CR21","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1016\/S1470-2045(13)70491-1","volume":"14","author":"JX Zhang","year":"2013","unstructured":"Zhang, J. X. et al. Prognostic and predictive value of a microRNA signature in stage II colon cancer: A microRNA expression analysis. Lancet Oncol. 14, 1295\u20131306 (2013).","journal-title":"Lancet Oncol."},{"key":"98381_CR22","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.4244\/EIJV9I12A245","volume":"9","author":"D Van Ron","year":"2014","unstructured":"Van Ron, D. et al. Tools and techniques\u2014statistics: How many variables are allowed in the logistic and Cox regression models?. EuroIntervention 9, 1472\u20131473 (2014).","journal-title":"EuroIntervention"},{"key":"98381_CR23","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"GC Yu","year":"2012","unstructured":"Yu, G. C., Wang, L., Han, Y. & He, Q. clusterProfiler: An R package for comparing biological themes among gene clusters. OMICS 16, 284\u2013287 (2012).","journal-title":"OMICS"},{"key":"98381_CR24","doi-asserted-by":"publisher","DOI":"10.1126\/science.aan2507","volume":"357","author":"M Uhlen","year":"2017","unstructured":"Uhlen, M. et al. A pathology atlas of the human cancer transcriptome. Science 357, eaan2507 (2017).","journal-title":"Science"},{"key":"98381_CR25","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/75556","volume":"25","author":"M Ashburner","year":"2000","unstructured":"Ashburner, M. et al. Gene ontology: Tool for the unification of biology. Nat. Genet. 25, 25\u201329 (2000).","journal-title":"Nat. Genet."},{"key":"98381_CR26","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1093\/nar\/gkaa970","volume":"49","author":"K Minoru","year":"2021","unstructured":"Minoru, K., Miho, F., Yoko, S., Mari, I. W. & Mao, T. KEGG: Integrating viruses and cellular organisms. Nucleic Acids Res. 49, 545\u2013551 (2021).","journal-title":"Nucleic Acids Res."},{"key":"98381_CR27","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.jhep.2017.03.011","volume":"67","author":"P Bertuccio","year":"2017","unstructured":"Bertuccio, P. et al. Global trends and predictions in hepatocellular carcinoma mortality. J. Hepatol. 67, 302\u2013329 (2017).","journal-title":"J. Hepatol."},{"key":"98381_CR28","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1038\/s41575-019-0186-y","volume":"16","author":"JD Yang","year":"2019","unstructured":"Yang, J. D. et al. A global view of hepatocellular carcinoma: Trends, risk, prevention and management. Nat. Rev. Gastroenterol. Hepatol. 16, 589\u2013604 (2019).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"98381_CR29","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1053\/j.gastro.2018.08.065","volume":"156","author":"L Kulik","year":"2019","unstructured":"Kulik, L. & El-Serag, H. B. Epidemiology and management of hepatocellular carcinoma. Gastroenterology 156, 477\u2013491 (2019).","journal-title":"Gastroenterology"},{"key":"98381_CR30","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1159\/000488035","volume":"7","author":"J Zhou","year":"2018","unstructured":"Zhou, J. et al. Guidelines for diagnosis and treatment of primary liver cancer in china (2017 edition). Liver Cancer 7, 235\u2013260 (2018).","journal-title":"Liver Cancer"},{"key":"98381_CR31","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.1002\/med.21696","volume":"40","author":"AM Liu","year":"2020","unstructured":"Liu, A. M. et al. A novel strategy for the diagnosis, prognosis, treatment, and chemoresistance of hepatocellular carcinoma: DNA methylation. Med. Res. Rev. 40, 1973\u20132018 (2020).","journal-title":"Med. Res. Rev."},{"key":"98381_CR32","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1001\/jamasurg.2018.4334","volume":"154","author":"XF Xu","year":"2019","unstructured":"Xu, X. F. et al. Risk factors, patterns, and outcomes of late recurrence after liver resection for hepatocellular carcinoma. JAMA Surg. 154, 209\u2013217 (2019).","journal-title":"JAMA Surg."},{"key":"98381_CR33","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1002\/bjs.10541","volume":"104","author":"H Kim","year":"2017","unstructured":"Kim, H. et al. Survival benefit of liver resection for Barcelona Clinic Liver Cancer stage B hepatocellular carcinoma. Br. J. Surg. 104, 1045\u20131052 (2017).","journal-title":"Br. J. Surg."},{"key":"98381_CR34","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1007\/s12072-020-10032-2","volume":"14","author":"ZH Chen","year":"2020","unstructured":"Chen, Z. H. et al. Actual long-term survival in HCC patients with portal vein tumor thrombus after liver resection: A nationwide study. Hepatol. Int. 14, 754\u2013764 (2020).","journal-title":"Hepatol. Int."},{"key":"98381_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/1758835919862692","volume":"11","author":"WQ Xu","year":"2019","unstructured":"Xu, W. Q. et al. Immunotherapy for hepatocellular carcinoma: Recent advances and future perspectives. Ther. Adv. Med. Oncol. 11, 1\u201315 (2019).","journal-title":"Ther. Adv. Med. Oncol."},{"key":"98381_CR36","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1016\/j.jhep.2019.10.026","volume":"72","author":"ZB Ding","year":"2020","unstructured":"Ding, Z. B. et al. Metabolic pathway analyses identify proline biosynthesis pathway as a promoter of liver tumorigenesis. J. Hepatol. 72, 725\u2013735 (2020).","journal-title":"J. Hepatol."},{"key":"98381_CR37","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.semcancer.2018.10.002","volume":"53","author":"N Ahmed","year":"2018","unstructured":"Ahmed, N., Escalona, R., Leung, D., Chan, E. & Kannourakis, G. Tumour microenvironment and metabolic plasticity in cancer and cancer stem cells: Perspectives on metabolic and immune regulatory signatures in chemoresistant ovarian cancer stem cells. Semin. Cancer Biol. 53, 265\u2013281 (2018).","journal-title":"Semin. Cancer Biol."},{"key":"98381_CR38","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.canlet.2019.08.003","volume":"463","author":"GX Fang","year":"2019","unstructured":"Fang, G. X. et al. Inhibition of GSK-3\u03b2 activity suppresses HCC malignant phenotype by inhibiting glycolysis via activating AMPK\/mTOR signaling. Cancer Lett. 463, 11\u201326 (2019).","journal-title":"Cancer Lett."},{"key":"98381_CR39","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1016\/j.jhep.2018.07.017","volume":"69","author":"M Gjorgjieva","year":"2018","unstructured":"Gjorgjieva, M. et al. Dietary exacerbation of metabolic stress leads to accelerated hepatic carcinogenesis in glycogen storage disease type Ia. J. Hepatol. 69, 1074\u20131087 (2018).","journal-title":"J. Hepatol."},{"key":"98381_CR40","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1002\/hep.28411","volume":"63","author":"Y Iwagami","year":"2016","unstructured":"Iwagami, Y. et al. Aspartate \u03b2-hydroxylase modulates cellular senescence through glycogen synthase kinase 3\u03b2 in hepatocellular carcinoma. Hepatology 63, 1213\u20131226 (2016).","journal-title":"Hepatology"},{"key":"98381_CR41","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1038\/s41419-018-0309-3","volume":"9","author":"N Zhang","year":"2018","unstructured":"Zhang, N. et al. Glycogen synthase kinase-3\u03b2 inhibition promotes lysosome-dependent degradation of c-FLIPL in hepatocellular carcinoma. Cell Death Dis. 9, 230\u2013242 (2018).","journal-title":"Cell Death Dis."},{"key":"98381_CR42","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1002\/hep.27996","volume":"62","author":"HH Chua","year":"2015","unstructured":"Chua, H. H. et al. RBMY, a novel inhibitor of glycogen synthase kinase 3\u03b2, increases tumor stemness and predicts poor prognosis of hepatocellular carcinoma. Hepatology 62, 1480\u20131496 (2015).","journal-title":"Hepatology"},{"key":"98381_CR43","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1186\/s12943-017-0748-y","volume":"16","author":"QR Xu","year":"2017","unstructured":"Xu, Q. R. et al. HSP90 promotes cell glycolysis, proliferation and inhibits apoptosis by regulating PKM2 abundance via Thr-328 phosphorylation in hepatocellular carcinoma. Mol. Cancer 16, 178\u2013191 (2017).","journal-title":"Mol. Cancer"},{"key":"98381_CR44","doi-asserted-by":"publisher","first-page":"17177","DOI":"10.1073\/pnas.2002898117","volume":"29","author":"H Wu","year":"2020","unstructured":"Wu, H. et al. A negative reciprocal regulatory axis between cyclin D1 and HNF4 \u03b1 modulates cell cycle progression and metabolism in the liver. PNAS 29, 17177\u201317186 (2020).","journal-title":"PNAS"},{"key":"98381_CR45","doi-asserted-by":"publisher","first-page":"2445","DOI":"10.1038\/bjc.2013.608","volume":"109","author":"JACM Goos","year":"2013","unstructured":"Goos, J. A. C. M. et al. Aurora kinase A (AURKA) expression in colorectal cancer liver metastasis is associated with poor prognosis. Br. J. Cancer 109, 2445\u20132452 (2013).","journal-title":"Br. J. Cancer"},{"key":"98381_CR46","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1007\/s00018-019-03310-2","volume":"77","author":"G Bertolin","year":"2020","unstructured":"Bertolin, G. & Tramier, M. Insights into the non-mitotic functions of Aurora kinase A: More than just cell division. Cell Mol. Life Sci. 77, 1031\u20131047 (2020).","journal-title":"Cell Mol. Life Sci."},{"key":"98381_CR47","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1053\/j.gastro.2018.10.030","volume":"156","author":"L Wang-Bishop","year":"2019","unstructured":"Wang-Bishop, L. et al. Gastrointestinal cancer cells with activated KRAS by preventing activation of RPS6KB1. Gastroenterology 156, 662\u2013675 (2019).","journal-title":"Gastroenterology"},{"key":"98381_CR48","doi-asserted-by":"publisher","first-page":"17727","DOI":"10.1002\/jcp.28398","volume":"234","author":"C Yang","year":"2019","unstructured":"Yang, C. et al. Effects of AURKA-mediated degradation of SOD2 on mitochondrial dysfunction and cartilage homeostasis in osteoarthritis. J. Cell Physiol. 234, 17727\u201317738 (2019).","journal-title":"J. Cell Physiol."},{"key":"98381_CR49","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.38111","volume":"7","author":"G Bertolin","year":"2018","unstructured":"Bertolin, G. et al. Aurora kinase A localises to mitochondria to control organelle dynamics and energy production. Elife 7, e38111 (2018).","journal-title":"Elife"},{"key":"98381_CR50","doi-asserted-by":"publisher","first-page":"3428","DOI":"10.1038\/onc.2016.490","volume":"24","author":"N Yang","year":"2017","unstructured":"Yang, N. et al. FOXM1 recruits nuclear Aurora kinase A to participate in a positive feedback loop essential for the self-renewal of breast cancer stem cells. Oncogene 24, 3428\u20133440 (2017).","journal-title":"Oncogene"},{"key":"98381_CR51","doi-asserted-by":"publisher","first-page":"10180","DOI":"10.1038\/ncomms10180","volume":"7","author":"FM Zheng","year":"2016","unstructured":"Zheng, F. M. et al. Nuclear AURKA acquires kinase-independent transactivating function to enhance breast cancer stem cell phenotype. Nat. Commun. 7, 10180\u201310196 (2016).","journal-title":"Nat. Commun."},{"key":"98381_CR52","doi-asserted-by":"publisher","first-page":"3737","DOI":"10.7150\/thno.25487","volume":"8","author":"CX Wu","year":"2018","unstructured":"Wu, C. X. et al. Blocking CDK1\/PDK1\/\u03b2-Catenin signaling by CDK1 inhibitor RO3306 increased the efficacy of sorafenib treatment by targeting cancer stem cells in a preclinical model of hepatocellular carcinoma. Theranostics 8, 3737\u20133750 (2018).","journal-title":"Theranostics"},{"key":"98381_CR53","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.ebiom.2017.04.014","volume":"19","author":"JL Cai","year":"2017","unstructured":"Cai, J. L. et al. Prognostic biomarker identification through integrating the gene signatures of hepatocellular carcinoma properties. EBioMedicine 19, 18\u201330 (2017).","journal-title":"EBioMedicine"},{"key":"98381_CR54","doi-asserted-by":"publisher","first-page":"23891","DOI":"10.1073\/pnas.1915108116","volume":"116","author":"TN Moiseeva","year":"2019","unstructured":"Moiseeva, T. N., Qian, C., Sugitani, N., Osmanbeyoglu, H. U. & Bakkenist, C. J. WEE1 kinase inhibitor AZD1775 induces CDK1 kinase-dependent origin firing in unperturbed G1- and S-phase cells. PNAS 116, 23891\u201323893 (2019).","journal-title":"PNAS"},{"key":"98381_CR55","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.canlet.2018.03.043","volume":"425","author":"WT Liu","year":"2018","unstructured":"Liu, W. T. et al. A novel strategy of integrated microarray analysis identifies CENPA, CDK1 and CDC20 as a cluster of diagnostic biomarkers in lung adenocarcinoma. Cancer Lett. 425, 43\u201353 (2018).","journal-title":"Cancer Lett."},{"key":"98381_CR56","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1016\/j.molcel.2016.06.023","volume":"63","author":"Y Roulland","year":"2016","unstructured":"Roulland, Y. et al. The flexible ends of CENP-A nucleosome are required for mitotic fidelity. Mol. Cell 63, 674\u2013685 (2016).","journal-title":"Mol. Cell"},{"key":"98381_CR57","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.jhep.2019.03.007","volume":"71","author":"J Bayo","year":"2019","unstructured":"Bayo, J. et al. A comprehensive study of epigenetic alterations in hepatocellular carcinoma identifies potential therapeutic targets. J. Hepatol. 71, 78\u201390 (2019).","journal-title":"J. Hepatol."},{"key":"98381_CR58","doi-asserted-by":"publisher","first-page":"11418","DOI":"10.1002\/jcb.28420","volume":"120","author":"BX Li","year":"2019","unstructured":"Li, B. X., Pu, K. & Wu, X. A. Identifying novel biomarkers in hepatocellular carcinoma by weighted gene co-expression network analysis. J. Cell Biochem. 120, 11418\u201311431 (2019).","journal-title":"J. Cell Biochem."},{"key":"98381_CR59","doi-asserted-by":"publisher","first-page":"5928","DOI":"10.1111\/jcmm.13863","volume":"22","author":"JY Long","year":"2018","unstructured":"Long, J. Y. et al. A four-gene-based prognostic model predicts overall survival in patients with hepatocellular carcinoma. J. Cell Mol. Med. 22, 5928\u20135938 (2018).","journal-title":"J. Cell Mol. Med."},{"key":"98381_CR60","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2017.1313371","volume":"6","author":"A Tosi","year":"2017","unstructured":"Tosi, A., Zanovello, P., Sommaggio, R. & Rosato, A. Identification of a HLA-A*0201-restricted immunogenic epitope from the universal tumor antigen DEPDC1. Oncoimmunology 6, e1313371 (2017).","journal-title":"Oncoimmunology"},{"key":"98381_CR61","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.canlet.2016.10.028","volume":"385","author":"J Ramalho-Carvalho","year":"2017","unstructured":"Ramalho-Carvalho, J. et al. Epigenetic disruption of miR-130a promotes prostate cancer by targeting SEC23B and DEPDC1. Cancer Lett. 385, 150\u2013159 (2017).","journal-title":"Cancer Lett."},{"key":"98381_CR62","doi-asserted-by":"publisher","first-page":"5829","DOI":"10.1158\/0008-5472.CAN-10-0255","volume":"70","author":"H Yosuke","year":"2010","unstructured":"Yosuke, H. et al. Cell-permeable peptide DEPDC1-ZNF224 interferes with transcriptional repression and oncogenicity in bladder cancer cells. Cancer Res. 70, 5829\u20135839 (2010).","journal-title":"Cancer Res."},{"key":"98381_CR63","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.110217","volume":"129","author":"W Li","year":"2020","unstructured":"Li, W., Pan, T. H., Jiang, W. & Zhao, H. Y. HCG18\/miR-34a-5p\/HMMR axis accelerates the progression of lung adenocarcinoma. Biomed. Pharmacother. 129, 110217 (2020).","journal-title":"Biomed. Pharmacother."},{"key":"98381_CR64","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1158\/0008-5472.CAN-16-1978","volume":"77","author":"LE Stevens","year":"2017","unstructured":"Stevens, L. E. et al. Extracellular matrix receptor expression in subtypes of lung adenocarcinoma potentiates outgrowth of micrometastases. Cancer Res. 77, 1905\u20131917 (2017).","journal-title":"Cancer Res."},{"key":"98381_CR65","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1038\/onc.2015.152","volume":"35","author":"P Khongkow","year":"2016","unstructured":"Khongkow, P. et al. Paclitaxel targets FOXM1 to regulate KIF20A in mitotic catastrophe and breast cancer paclitaxel resistance. Oncogene 35, 990\u20131002 (2016).","journal-title":"Oncogene"},{"key":"98381_CR66","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1002\/iub.1726","volume":"70","author":"MQ Lu","year":"2018","unstructured":"Lu, M. Q. et al. Aberrant KIF20A expression might independently predict poor overall survival and recurrence-free survival of hepatocellular carcinoma. IUBMB Life 70, 328\u2013335 (2018).","journal-title":"IUBMB Life"},{"key":"98381_CR67","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1186\/s12935-019-0882-2","volume":"19","author":"L Yao","year":"2019","unstructured":"Yao, L., Wang, L., Cao, Z. G., Hu, X. & Shao, Z. M. High expression of metabolic enzyme PFKFB4 is associated with poor prognosis of operable breast cancer. Cancer Cell Int. 19, 165\u2013172 (2019).","journal-title":"Cancer Cell Int."},{"key":"98381_CR68","doi-asserted-by":"publisher","first-page":"6248","DOI":"10.7150\/thno.28721","volume":"8","author":"RF Gao","year":"2018","unstructured":"Gao, R. F. et al. CD44ICD promotes breast cancer stemness via PFKFB4-mediated glucose metabolism. Theranostics 8, 6248\u20136462 (2018).","journal-title":"Theranostics"},{"key":"98381_CR69","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1158\/1078-0432.CCR-17-1475","volume":"24","author":"QY Wang","year":"2018","unstructured":"Wang, Q. Y. et al. Etk interaction with PFKFB4 modulates chemoresistance of small-cell lung cancer by regulating autophagy. Clin. Cancer Res. 24, 950\u2013962 (2018).","journal-title":"Clin. Cancer Res."},{"key":"98381_CR70","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1038\/bjc.2017.292","volume":"117","author":"M Li","year":"2017","unstructured":"Li, M. et al. Activation of an AKT\/FOXM1\/STMN1 pathway drives resistance to tyrosine kinase inhibitors in lung cancer. Br. J. Cancer 117, 974\u2013983 (2017).","journal-title":"Br. J. Cancer"},{"key":"98381_CR71","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1111\/cas.14262","volume":"111","author":"R Zhang","year":"2020","unstructured":"Zhang, R. et al. STMN1 upregulation mediates hepatocellular carcinoma and hepatic stellate cell crosstalk to aggravate cancer by triggering the MET pathway. Cancer Sci. 111, 406\u2013417 (2020).","journal-title":"Cancer Sci."},{"key":"98381_CR72","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1084\/jem.20170015","volume":"214","author":"Y Xia","year":"2017","unstructured":"Xia, Y. et al. RNF8 mediates histone H3 ubiquitylation and promotes glycolysis and tumorigenesis. J. Exp. Med. 214, 1843\u20131855 (2017).","journal-title":"J. Exp. Med."},{"key":"98381_CR73","doi-asserted-by":"publisher","first-page":"337","DOI":"10.3390\/cancers10090337","volume":"10","author":"AP Nayak","year":"2018","unstructured":"Nayak, A. P., Kapur, A., Barroilhet, L. & Patankar, M. S. Oxidative phosphorylation: A target for novel therapeutic strategies against ovarian cancer. Cancers 10, 337\u2013351 (2018).","journal-title":"Cancers"},{"key":"98381_CR74","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.ejca.2019.09.002","volume":"121","author":"AS Dias","year":"2019","unstructured":"Dias, A. S., Almeida, C. R., Helguero, L. A. & Duarte, I. F. Metabolic crosstalk in the breast cancer microenvironment. Eur. J. Cancer 121, 154\u2013171 (2019).","journal-title":"Eur. J. Cancer"},{"key":"98381_CR75","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1002\/med.21511","volume":"39","author":"MC Oca\u00f1a","year":"2019","unstructured":"Oca\u00f1a, M. C., Mart\u00ednez-Poveda, B., Quesada, A. R. & Medina, M. \u00c1. Metabolism within the tumor microenvironment and its implication on cancer progression: An ongoing therapeutic target. Med. Res. Rev. 39, 70\u2013113 (2019).","journal-title":"Med. Res. Rev."},{"key":"98381_CR76","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1158\/1078-0432.CCR-18-1133","volume":"25","author":"SL Locatelli","year":"2019","unstructured":"Locatelli, S. L. et al. Targeting cancer cells and tumor microenvironment in preclinical and clinical models of hodgkin lymphoma using the dual PI3K\u03b4\/\u03b3 inhibitor RP6530. Clin. Cancer Res. 25, 1098\u20131112 (2019).","journal-title":"Clin. Cancer Res."},{"key":"98381_CR77","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nmeth.3337","volume":"12","author":"AM Newman","year":"2015","unstructured":"Newman, A. M. et al. Robust enumeration of cell subsets from tissue expression profiles. Nat. Methods 12, 453\u2013457 (2015).","journal-title":"Nat. Methods"},{"key":"98381_CR78","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1038\/s41586-019-1906-8","volume":"577","author":"F Petitprez","year":"2020","unstructured":"Petitprez, F. et al. B cells are associated with survival and immunotherapy response in sarcoma. Nature 577, 556\u2013560 (2020).","journal-title":"Nature"},{"key":"98381_CR79","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1038\/s41586-019-1922-8","volume":"577","author":"BA Helmink","year":"2020","unstructured":"Helmink, B. A. et al. B cells and tertiary lymphoid structures promote immunotherapy response. Nature 577, 549\u2013555 (2020).","journal-title":"Nature"},{"key":"98381_CR80","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1016\/j.cell.2019.10.028","volume":"179","author":"DP Hollern","year":"2019","unstructured":"Hollern, D. P. et al. B cells and T follicular helper cells mediate response to checkpoint inhibitors in high mutation burden mouse models of breast cancer. Cell 179, 1191\u20131206 (2019).","journal-title":"Cell"},{"key":"98381_CR81","doi-asserted-by":"publisher","first-page":"279","DOI":"10.21037\/atm.2020.03.53","volume":"8","author":"JY Gu","year":"2020","unstructured":"Gu, J. Y. et al. Activating miRNA-mRNA network in gemcitabine-resistant pancreatic cancer cell associates with alteration of memory CD4+ T cells. Ann. Transl. Med. 8, 279\u2013293 (2020).","journal-title":"Ann. Transl. Med."},{"key":"98381_CR82","doi-asserted-by":"publisher","first-page":"15338","DOI":"10.1038\/ncomms15338","volume":"8","author":"T Kondo","year":"2017","unstructured":"Kondo, T. et al. Notch-mediated conversion of activated T cells into stem cell memory-like T cells for adoptive immunotherapy. Nat. Commun. 8, 15338 (2017).","journal-title":"Nat. Commun."},{"key":"98381_CR83","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/s12951-019-0520-0","volume":"17","author":"LS Ortega","year":"2019","unstructured":"Ortega, L. S., Yadileiny, P., Sonia, P. Y. & Domingo, F. B. Magnetic targeting of adoptively transferred tumour-specific nanoparticle-loaded CD8+ T cells does not improve their tumour infiltration in a mouse model of cancer but promotes the retention of these cells in tumour-draining lymph nodes. J. Nanobiotechnol. 17, 87\u2013110 (2019).","journal-title":"J. Nanobiotechnol."},{"key":"98381_CR84","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1038\/s41419-018-0818-0","volume":"9","author":"Y Yang","year":"2018","unstructured":"Yang, Y. et al. Crosstalk between hepatic tumor cells and macrophages via Wnt\/\u03b2-catenin signaling promotes M2-like macrophage polarization and reinforces tumor malignant behaviors. Cell Death. Dis. 9, 793\u2013806 (2018).","journal-title":"Cell Death. Dis."},{"key":"98381_CR85","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1186\/s40425-018-0452-5","volume":"6","author":"ZF Wen","year":"2018","unstructured":"Wen, Z. F. et al. Tumor cell-released autophagosomes (TRAPs) promote immunosuppression through induction of M2-like macrophages with increased expression of PD-L1. J. Immunother Cancer 6, 116\u2013151 (2018).","journal-title":"J. Immunother Cancer"},{"key":"98381_CR86","doi-asserted-by":"publisher","first-page":"4276","DOI":"10.7150\/thno.20999","volume":"7","author":"CR Zhang","year":"2017","unstructured":"Zhang, C. R. et al. Noninvasive imaging of CD206-positive M2 macrophages as an early biomarker for post-chemotherapy tumor relapse and lymph node metastasis. Theranostics 7, 4276\u20134288 (2017).","journal-title":"Theranostics"},{"key":"98381_CR87","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.cytogfr.2017.04.003","volume":"35","author":"KE Beckermann","year":"2017","unstructured":"Beckermann, K. E., Dudzinski, S. O. & Rathmell, J. C. Dysfunctional T cell metabolism in the tumor microenvironment. Cytokine Growth Factor Rev. 35, 7\u201314 (2017).","journal-title":"Cytokine Growth Factor Rev."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-98381-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-98381-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-98381-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T16:08:41Z","timestamp":1670083721000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-98381-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,23]]},"references-count":87,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["98381"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-98381-2","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,23]]},"assertion":[{"value":"13 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"18875"}}